Outlook Therapeutics
Earnings Surprise
Analysts estimated OTLK earnings of $-0.18 per share this quarter (Q1). OTLK's actual earnings were $-0.22 per share.
OTLK EPS surprise of -24.43%Analysts estimated OTLK earnings of $-0.26 per share this quarter (Q4). OTLK's actual earnings were $-0.19 per share.
OTLK EPS surprise of 26.47%Analysts estimated OTLK earnings of $-0.40 per share this quarter (Q3). OTLK's actual earnings were $-0.55 per share.
OTLK EPS surprise of -37.09%Analysts estimated OTLK earnings of $-0.61 per share this quarter (Q2). OTLK's actual earnings were $-0.40 per share.
OTLK EPS surprise of 34.43%Analysts estimated OTLK earnings of $-0.79 per share this quarter (Q1). OTLK's actual earnings were $0.72 per share.
OTLK EPS surprise of 191.08%Analysts estimated OTLK earnings of $-0.85 per share this quarter (Q4). OTLK's actual earnings were $0.76 per share.
OTLK EPS surprise of 189.34%Analysts estimated OTLK earnings of $-1.02 per share this quarter (Q3). OTLK's actual earnings were $-0.83 per share.
OTLK EPS surprise of 18.47%Analysts estimated OTLK earnings of $-0.87 per share this quarter (Q2). OTLK's actual earnings were $-1.55 per share.
OTLK EPS surprise of -78.78%Analysts estimated OTLK earnings of $-1.02 per share this quarter (Q1). OTLK's actual earnings were $-0.80 per share.
OTLK EPS surprise of 27.50%